West Bengal Hybrid Seeds & Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 2.50 Cr
as on 12-12-2024
- Company Age 23 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 21.23%
(FY 2022)
- Profit 686.76%
(FY 2022)
- Ebitda 9631.84%
(FY 2022)
- Net Worth 43.00%
(FY 2022)
- Total Assets 8.62%
(FY 2022)
About West Bengal Hybrid Seeds & Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Agarwalla, Swajan Agarwala, Rajkumar Agarwalla, and Two other members serve as directors at the Company.
- CIN/LLPIN
U01122WB2001PTC093863
- Company No.
093863
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2001
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at West Bengal Hybrid Seeds & Biotech?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Agarwalla  | Director | 18-Oct-2001 | Current |
| Swajan Agarwala | Director | 17-Aug-2015 | Current |
| Rajkumar Agarwalla | Director | 18-Oct-2001 | Current |
| Suresh Agrawal | Director | 18-Feb-2014 | Current |
| Biswanath Mazumdar | Director | 22-May-2020 | Current |
Financial Performance and Corporate Structure Insights of West Bengal Hybrid Seeds & Biotech.
West Bengal Hybrid Seeds & Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.23% increase. The company also saw a substantial improvement in profitability, with a 686.76% increase in profit. The company's net worth Soared by an impressive increase of 43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of West Bengal Hybrid Seeds & Biotech?
In 2020, West Bengal Hybrid Seeds & Biotech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- M A Construction & Trading Company Pvt LtdActive 33 years 15 days
Arun Agarwalla and Rajkumar Agarwalla are mutual person
- Taxaco Consultancy Pvt LtdActive 28 years 5 months
Arun Agarwalla and Swajan Agarwala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at West Bengal Hybrid Seeds & Biotech?
Unlock and access historical data on people associated with West Bengal Hybrid Seeds & Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of West Bengal Hybrid Seeds & Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped West Bengal Hybrid Seeds & Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
